Profile
Mira Leiwant currently works at Anika Therapeutics, Inc., as Senior VP-Quality, Regulatory & Clinical Affairs.
Ms. Leiwant also formerly worked at LifeCell Corp., as Senior Director-Regulatory & Quality Engineering and BTG International, Inc., as Vice President-Regulatory Affairs.
Ms. Leiwant received her undergraduate degree in 1997 and graduate degree in 1998 from Cornell University.
Mira Leiwant active positions
| Companies | Position | Start |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-10-13 |
Former positions of Mira Leiwant
| Companies | Position | End |
|---|---|---|
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | General Counsel | - |
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Corporate Officer/Principal | - |
Training of Mira Leiwant
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Health Technology |
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Finance |
- Stock Market
- Insiders
- Mira Leiwant
















